Impact of diabetes on coronary severity and cardiovascular outcomes in patients with heterozygous familial hypercholesterolaemia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of diabetes on coronary severity and cardiovascular outcomes in patients with heterozygous familial hypercholesterolaemia
Authors
Keywords
-
Journal
European Journal of Preventive Cardiology
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-03-06
DOI
10.1093/eurjpc/zwab042
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association
- (2020) Suzanne V. Arnold et al. CIRCULATION
- Genetic predisposition to smoking in relation to 14 cardiovascular diseases
- (2020) Susanna C Larsson et al. EUROPEAN HEART JOURNAL
- Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial
- (2020) Wolfram Doehner et al. EUROPEAN HEART JOURNAL
- High cardiovascular risk of patients with type 2 diabetes is only partially attributed to angiographic burden of atherosclerosis
- (2020) Simone Battermann et al. Diabetes & Vascular Disease Research
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Baseline and on-statin treatment lipoprotein(a) levels for predicting cardiovascular events in patients with familial hypercholesterolemia
- (2019) Ye-Xuan Cao et al. ATHEROSCLEROSIS
- 1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes—2020
- (2019) American Diabetes Association DIABETES CARE
- Diferencias clínicas y genéticas de los pacientes con hipercolesterolemia familiar heterocigota con y sin diabetes mellitus tipo 2
- (2019) Elisenda Climent et al. REVISTA ESPANOLA DE CARDIOLOGIA
- Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk
- (2018) Brian A Bergmark et al. EUROPEAN HEART JOURNAL
- Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering
- (2018) Eliano P. Navarese et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Diabetes is Associated with an Increased Risk of Cardiovascular Disease in Patients with Familial Hypercholesterolemia
- (2018) Martine Paquette et al. Journal of Clinical Lipidology
- 2018 ESC/ESH Guidelines for the management of arterial hypertension
- (2018) Bryan Williams et al. JOURNAL OF HYPERTENSION
- Genetic basis of index patients with familial hypercholesterolemia in Chinese population: mutation spectrum and genotype-phenotype correlation
- (2018) Di Sun et al. Lipids in Health and Disease
- Clinical and genetic characteristics of familial hypercholesterolemia patients with type 2 diabetes
- (2018) D. Sun et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Familial Hypercholesterolemia Phenotype in Chinese Patients Undergoing Coronary AngiographyHighlights
- (2016) Jian-Jun Li et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)CLINICAL PERSPECTIVE
- (2016) Sarah D. de Ferranti et al. CIRCULATION
- Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United StatesCLINICAL PERSPECTIVE
- (2016) Emil M. deGoma et al. Circulation-Cardiovascular Genetics
- Interpretation of the evidence for the efficacy and safety of statin therapy
- (2016) Rory Collins et al. LANCET
- Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United StatesCLINICAL PERSPECTIVE
- (2016) Emil M. deGoma et al. Circulation-Cardiovascular Genetics
- The Agenda for Familial Hypercholesterolemia
- (2015) Samuel S. Gidding et al. CIRCULATION
- Elevated Risk of an Intermediate or High SYNTAX Score in Subjects with Impaired Fasting Glucose
- (2015) Xishan Yang et al. INTERNAL MEDICINE
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: A study of a cohort of 14,000 mutation carriers
- (2014) Joost Besseling et al. ATHEROSCLEROSIS
- Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort
- (2014) Matthew D Allard et al. Lipids in Health and Disease
- Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application
- (2013) Christoph Sinning et al. Clinical Research in Cardiology
- Severity of coronary atherosclerosis in patients with a first acute coronary event: a diabetes paradox
- (2012) G. Niccoli et al. EUROPEAN HEART JOURNAL
- Predictors of Outcomes in Medically Treated Patients With Acute Coronary Syndromes After Angiographic Triage
- (2010) Kenji Goto et al. CIRCULATION
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
- (2008) LANCET
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
- (2008) William Duckworth et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started